CD57 MicroBeads, human

CD57 MicroBeads were developed for the positive selection or depletion of CD57+ cells from human PBMCs, body fluids, or single-cell suspensions from tissue (e.g. lymphoid tissues).

qualityAssuranceSatisfaction
guaranteed
more »
Product data and images for CD57 MicroBeads, human
Figure 1

CD57+ cells were isolated from human PBMCs using CD57 MicroBeads, an MS Column, and a MiniMACS™ Separator. Cells were stained with CD57-APC and analyzed by flow cytometry.

Specifications for CD57 MicroBeads, human
Overview

CD57 MicroBeads were developed for the positive selection or depletion of CD57+ cells from human PBMCs, body fluids, or single-cell suspensions from tissue (e.g. lymphoid tissues).

Detailed product information
Background information

The CD57 antigen, also known as HNK-1 or Leu-7, is an oligosaccharide antigenic moiety bound to surface proteins of certain cell types. CD57 is present on 15–20% of PBMCs, including subsets of NK cells and T cells and some neural cell types.1,2

CD57 has been shown to be expressed on late-stage CD8+ effector cells3 and terminally differentiated NK cells.

The frequency of CD57+ T lymphocytes is raised in a variety of diseases, for example, in rheumatoid arthritis4. Its expression is also increased on proliferation-incompentent or chronically activated CD8+ T cells in persistent viral infections, such as HIV.5

Columns

For positive selection: MS, LS, XS, or autoMACS® Columns. For depletion: LD, D, or autoMACS Columns.

Resources for CD57 MicroBeads, human
Documents and Protocols
Citations for CD57 MicroBeads, human
Publications
  1. Mechtersheimer, G. et al. (1991) Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res. 51: 1300-1307
  2. Ong, E. et al. (2002) Biosynthesis of HNK-1 glycans on O-linked oligosaccharides attached to the neural cell adhesion molecule (NCAM): the requirement for core 2 β1,6-N-acetylglucosaminyltransferase and the muscle-specific domain in NCAM. J. Biol. Chem. 277: 18182-18190
  3. Dupuy d'Angeac, A. et al. (1993) Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum 36: 608-612
  4. Brenchley, J. M. et al. (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101: 2711-2720
  5. Palmer, B. E. et al. (2005) Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 175: 8415-8423

You have previously chosen International as your location.
What do you want to do?